RELATIVE CONTRIBUTIONS OF PERIPHERAL AND CENTRAL SOURCES TO LEVELS OFIL-1-ALPHA IN THE CEREBRAL-CORTEX OF MICE - ASSESSMENT WITH SPECIES-SPECIFIC ENZYME IMMUNOASSAYS
Wa. Banks et Aj. Kastin, RELATIVE CONTRIBUTIONS OF PERIPHERAL AND CENTRAL SOURCES TO LEVELS OFIL-1-ALPHA IN THE CEREBRAL-CORTEX OF MICE - ASSESSMENT WITH SPECIES-SPECIFIC ENZYME IMMUNOASSAYS, Journal of neuroimmunology, 79(1), 1997, pp. 22-28
The peripheral administration or release of cytokines is associated wi
th central nervous system (CNS) effects that are often due to the acti
ons of cytokines behind the blood-brain barrier (BBB). It is not known
whether the majority of cytokine behind the BBB is derived from blood
ol is released from the CNS in response to peripheral signals. We add
ressed this question for interleukin-1 alpha (IL-1 alpha) by infusing
human IL-1 alpha (humIL-1 alpha) into mice and measuring humIL-1 alpha
and murine IL-1 alpha (murIL-1 alpha) in cerebral cortex and serum wi
th specific, sensitive enzyme immunoassays. In adult mice receiving 50
mu g/kg-24 h of humIL-1 alpha subcutaneously for 48 h, brain and bloo
d samples contained hum-1 alpha but no murIL-1 alpha. This shows that
in our study blood-borne IL-1 alpha did not self-stimulate its release
in blood or brain. The presence of humIL-1 alpha in brain could only
have originated from blood, where it was administered; the brain/blood
ratio of 0.126 ml/g indicates that at steady state, brain levels reac
h about 12% of blood levels. In neonatal mice, both murIL-1 alpha and
humIL-1 alpha: were detected in brain and blood after the acute subcut
aneous injection of humIL-1 alpha. However, the vast majority of immun
oactivity in blood and brain was humIL-1 alpha. These results show tha
t most of the IL-1 alpha appearing in response to circulating IL-I a i
n areas of the CNS behind the BBB is due to passage across the BBB and
not to release from stores endogenous to the CNS. (C) 1997 Elsevier S
cience B.V.